0

    540788

    ASPIRA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Aspira Pathlab & Diagnostics L Share Price Today

    Investment Returns

    Over 1 Month -23.29% Over 3 Months 52.26% Over 6 Months 40.65% Over 1 Year 71.80%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Aspira Pathlab & Diagnostics L fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 88.20
    • P/E Ratio (TTM) 1,804.00
    • Beta 0.07
    • Book Value / share 11.88
    • Return on equity 16.88%
    • EPS (TTM) 0.05
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.69
    info icon alternate text

    Aspira Pathlab & Diagnostics L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 6.52
    Operating Expense 7.35
    Net Profit -0.69
    Net Profit Margin (%) -10.58
    Earnings Per Share (EPS) -0.67
    EBITDA -0.18
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 5.12
    Operating Expense 6.81
    Net Profit -1.56
    Net Profit Margin (%) -30.46
    Earnings Per Share (EPS) -1.52
    EBITDA -1.08
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 8.09
    Operating Expense 6.39
    Net Profit 1.84
    Net Profit Margin (%) 22.74
    Earnings Per Share (EPS) 1.78
    EBITDA 2.34
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 5.25
    Operating Expense 4.88
    Net Profit 0.47
    Net Profit Margin (%) 8.95
    Earnings Per Share (EPS) 0.46
    EBITDA 0.92
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 5.78
    Operating Expense 5.18
    Net Profit 0.72
    Net Profit Margin (%) 12.45
    Earnings Per Share (EPS) 0.70
    EBITDA 1.18
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 24.98
    Operating Expense 25.45
    Net Profit 0.05
    Net Profit Margin (%) 0.20
    Earnings Per Share (EPS) 0.05
    EBITDA 1.98
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 22.00
    Operating Expense 20.32
    Net Profit 2.07
    Net Profit Margin (%) 9.40
    Earnings Per Share (EPS) 2.01
    EBITDA 3.91
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 13.20
    Operating Expense 16.30
    Net Profit -2.67
    Net Profit Margin (%) -20.22
    Earnings Per Share (EPS) -2.60
    EBITDA -0.75
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 14.46
    Operating Expense 14.87
    Net Profit -0.09
    Net Profit Margin (%) -0.62
    Earnings Per Share (EPS) -0.09
    EBITDA 1.92
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 19.54
    Operating Expense 15.18
    Net Profit 4.46
    Net Profit Margin (%) 22.82
    Earnings Per Share (EPS) 4.33
    EBITDA 6.47
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.03
    ROE % 16.47
    ROCE % 11.47
    Total Debt to Total Equity 0.15
    EBITDA Margin 17.59
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 5.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.15
    EBITDA Margin -5.76
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 7.08
    ROE % 16.88
    ROCE % 11.71
    Total Debt to Total Equity 0.15
    EBITDA Margin 17.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 5.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.16
    EBITDA Margin -5.76
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 7.60
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.20
    EBITDA Margin 13.28
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 7.64
    ROE % 23.08
    ROCE % 17.56
    Total Debt to Total Equity 0.19
    EBITDA Margin 33.11
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3.29
    ROE % 15.17
    ROCE % 11.51
    Total Debt to Total Equity 0.70
    EBITDA Margin 24.46
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.14
    Total Assets 17.46
    Total Liabilities 17.46
    Total Equity 12.16
    Share Outstanding 1
    Price to Book Ratio 12.04
    Return on Assets (%) 11.58
    Return on Capital (%) 15.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.38
    Total Assets 14.70
    Total Liabilities 14.70
    Total Equity 10.14
    Share Outstanding 1
    Price to Book Ratio 6.11
    Return on Assets (%) -18.16
    Return on Capital (%) -23.82
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.14
    Total Assets 17.51
    Total Liabilities 17.51
    Total Equity 12.21
    Share Outstanding 1
    Price to Book Ratio 12.04
    Return on Assets (%) 11.83
    Return on Capital (%) 15.44
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.38
    Total Assets 14.70
    Total Liabilities 14.70
    Total Equity 10.14
    Share Outstanding 1
    Price to Book Ratio 6.11
    Return on Assets (%) -18.16
    Return on Capital (%) -23.82
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.34
    Total Assets 17.34
    Total Liabilities 17.34
    Total Equity 12.75
    Share Outstanding 1
    Price to Book Ratio 3.66
    Return on Assets (%) -0.51
    Return on Capital (%) -0.65
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 18.13
    Total Liabilities 18.13
    Total Equity 12.78
    Share Outstanding 1
    Price to Book Ratio 8.48
    Return on Assets (%) 24.58
    Return on Capital (%) 32.67
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.18
    Total Assets 11.77
    Total Liabilities 11.77
    Total Equity 8.31
    Share Outstanding 1
    Price to Book Ratio 8.66
    Return on Assets (%) 11.72
    Return on Capital (%) 14.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.02
    Cash from Operations 1.82
    Cash from Investing 0.11
    Cash from Financing -0.99
    Net change in Cash 0.94
    Free Cash Flow 2.17
    Particulars MAR 2024 (Values in Cr)
    Net Income -2.67
    Cash from Operations 1.05
    Cash from Investing 0.13
    Cash from Financing -0.95
    Net change in Cash 0.23
    Free Cash Flow 1.31
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.07
    Cash from Operations 1.87
    Cash from Investing 0.06
    Cash from Financing -0.99
    Net change in Cash 0.94
    Free Cash Flow 2.22
    Particulars MAR 2024 (Values in Cr)
    Net Income -2.67
    Cash from Operations 1.05
    Cash from Investing 0.13
    Cash from Financing -0.95
    Net change in Cash 0.23
    Free Cash Flow 1.31
    Particulars MAR 2023 (Values in Cr)
    Net Income -0.08
    Cash from Operations -0.01
    Cash from Investing 0.15
    Cash from Financing -0.93
    Net change in Cash -0.78
    Free Cash Flow 0.11
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.45
    Cash from Operations 2.03
    Cash from Investing -0.51
    Cash from Financing -1.35
    Net change in Cash 0.16
    Free Cash Flow 2.62
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.38
    Cash from Operations 5.67
    Cash from Investing -0.09
    Cash from Financing -2.17
    Net change in Cash 3.40
    Free Cash Flow 5.79
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8901.10 65.43 13.51 127984.16 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 50.37 22.79 2.74 94.40 40.75 76.00
    SHREE PACETRONIX LTD. 151.35 18.06 3.18 56.75 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.95 0.00 2.66 22.35 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8901.10 85.25 12.84 127984.16 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.59 0.00 -9.38 28.83 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5867.80 26.26 4.86 6419.37 5010.00 6725.00

    Aspira Pathlab & Diagnostics L shareholding pattern

    Holding
    81.6%
    18.39%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Aspira Pathlab & Diagnostics L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    85.70 -4.98 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 100.00
    • 26 Days 113.90
    • 10 Days 108.10
    • 50 Days 107.20
    • 12 Days 110.00
    • 100 Days 93.60
    • 20 Days 113.70
    • 200 Days 80.80
    90.20 PIVOT
    First Support 90.20 First Resistance 90.20 Second Support 90.20 Second Resistance 90.20 Third Support 90.20 Third Resistance 90.20
    RSI 23.38 ADX 29.73 MACD -3.82 Williams % R -100.00 Commodity Channel Index (CCI) -210.84
    Date 2026-07-14 Week 1070.00 Same Day 214.00 Month 2075.00
    1 Year 0.08 3 Year 0.09
    Over 1 Month
    -23.29% down
    Over 1 Year
    71.80% down
    Over 3 Months
    52.26% down
    Over 3 Years
    47.77% down
    Over 6 Months
    40.65% down
    Over 5 Years
    21.19% down

    Aspira Pathlab & Diagnostics L Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    Aspira Pathlab & Diagnostics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 85.70 as on Jul 15 2026 03:29 PM.

    What is the Market Cap of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    The market cap of Aspira Pathlab & Diagnostics Ltd for NSE ₹ 0.00 & for BSE ₹ 88.20 as on Jul 15 2026 03:29 PM.

    What is the 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    The 52 Week High and Low of Aspira Pathlab & Diagnostics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 135.88 and ₹ 49.00.

    What is 1 year return for Aspira Pathlab & Diagnostics Ltd?

    Answer Field

    The 1 year returns on the stock has been 71.80%.

    What is the P/E Ratio of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    As on Jul 15 2026 03:29 PM the price-to-earnings (PE) ratio for Aspira Pathlab & Diagnostics Ltd share is 1804.00.

    What is the PB ratio of Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    As on Jul 15 2026 03:29 PM, the price-to-book (PB) ratio for Aspira Pathlab & Diagnostics Ltd share is 11.88.

    How to Buy Aspira Pathlab & Diagnostics Ltd Share?

    Answer Field

    You can trade in Aspira Pathlab & Diagnostics Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Aspira Pathlab & Diagnostics Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Aspira Pathlab & Diagnostics Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Aspira Pathlab & Diagnostics Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |